Bacterial adrenergic sensors regulate virulence of enteric pathogens in the gut

mBio

Volumn 7, Issue 3, 2016, Pages

  Moreira, Cristiano G ^a,b   Russell, Regan ^a   Mishra, Animesh Anand ^a   Narayanan, Sanjeev ^c   Ritchie, Jennifer M ^d   Waldor, Matthew K ^e   Curtis, Meredith M ^a   Winter, Sebastian E ^a   Weinshenker, David ^f   Sperandio, Vanessa ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c KANSAS STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN; QSEC PROTEIN; QSEE PROTEIN; UNCLASSIFIED DRUG; EPINEPHRINE; ESCHERICHIA COLI PROTEIN; PHOSPHOPROTEIN; QSEC PROTEIN, E COLI; QSEE PROTEIN, E COLI; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; CITROBACTER RODENTIUM; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; INFANT; INTESTINE INFECTION; LOCUS OF ENTEROCYTE EFFACEMENT; LOCUS OF ENTEROCYTE EFFACEMENT GENE; MOUSE; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PRIORITY JOURNAL; QSEC GENE; QSEE GENE; ANIMAL; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; GASTROINTESTINAL TRACT; GENETICS; HOST PATHOGEN INTERACTION; INTESTINE CELL; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

ANIMALS; CITROBACTER RODENTIUM; DOPAMINE BETA-HYDROXYLASE; ENTEROBACTERIACEAE INFECTIONS; ENTEROCYTES; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EPINEPHRINE; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; HOST-PATHOGEN INTERACTIONS; MICE; MICE, KNOCKOUT; NOREPINEPHRINE; PHOSPHOPROTEINS; RECEPTORS, ADRENERGIC; VASOCONSTRICTOR AGENTS; VIRULENCE;

EID: 84978993727     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00826-16     Document Type: Article

References (83)

1. Grenham S, Clarke G, Cryan JF, Dinan TG. 2011. Brain-gut-microbe communication in health and disease. Front Physiol 2:94. http://dx.doi.org/10.3389/fphys.2011.00094.
2. Furness JB. 2000. Types of neurons in the enteric nervous system. J Auton Nerv Syst 81:87-96. http://dx.doi.org/10.1016/S0165-1838(00)00127-2.
3. Purves D, Fitzpatrick D, Williams SM, McNamara JO, Augustine GJ, Katz LC, LaMantia A. 2001. Neuroscience, 2nd ed. Sinauer Associates, Inc., Sunderland, MA. http://dx.doi.org/10.4249/scholarpedia.7204.
4. Hörger S, Schultheiss G, Diener M. 1998. Segment-specific effects of epinephrine on ion transport in the colon of the rat. Am J Physiol 275: G1367-G1376.
5. Asano Y, Hiramoto T, Nishino R, Aiba Y, Kimura T, Yoshihara K, Koga Y, Sudo N. 2012. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303:G1288-G1295. http://dx.doi.org/10.1152/ajpgi.00341.2012.
6. Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ. 2012. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun 80:2826-2834. http://dx.doi.org/10.1128/IAI.00283-12.
7. Rasko DA, Moreira CG, Li DR, Reading NC, Ritchie JM, Waldor MK, Williams N, Taussig R, Wei S, Roth M, Hughes DT, Huntley JF, Fina MW, Falck JR, Sperandio V. 2008. Targeting QseC signaling and virulence for antibiotic development. Science 321:1078-1080. http://dx.doi.org/10.1126/science.1160354.
8. Moreira CG, Weinshenker D, Sperandio V. 2010. QseC mediates Salmonella enterica serovar Typhimurium virulence in vitro and in vivo. Infect Immun 78:914-926. http://dx.doi.org/10.1128/IAI.01038-09.
9. Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseCmediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol Microbiol 73:1020-1031. http://dx.doi.org/10.1111/j.1365-2958.2009.06826.x.
10. Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, Monack DM. 2007. In vivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci U S A 104:6037-6042. http://dx.doi.org/10.1073/pnas.0609675104.
11. Moreira CG, Sperandio V. 2012. Interplay between the QseC and QseE bacterial adrenergic sensor kinases in Salmonella enterica serovar Typhimurium pathogenesis. Infect Immun 80:4344-4353. http://dx.doi.org/10.1128/IAI.00803-12.
12. Unal CM, Singh B, Fleury C, Singh K, Chávez de Paz L, Svensäter G, Riesbeck K. 2012. QseC controls biofilm formation of non-typeable Haemophilus influenzae in addition to an AI-2-dependent mechanism. Int J Med Microbiol 302:261-269. http://dx.doi.org/10.1016/j.ijmm.2012.07.013.
13. Khajanchi BK, Kozlova EV, Sha J, Popov VL, Chopra AK. 2012. The two-component QseBC signalling system regulates in vitro and in vivo virulence of Aeromonas hydrophila. Microbiology 158:259-271. http://dx.doi.org/10.1099/mic.0.051805-0.
14. Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ. 2012. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun 80:2826-2834. http://dx.doi.org/10.1128/IAI.00283-12.
15. Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 80:1516-1529. http://dx.doi.org/10.1111/j.1365-2958.2011.07660.x.
16. Novak EA, Shao H, Daep CA, Demuth DR. 2010. Autoinducer-2 and QseC control biofilm formation and in vivo virulence of Aggregatibacter actinomycetemcomitans. Infect Immun 78:2919-2926. http://dx.doi.org/10.1128/IAI.01376-09.
17. Mokrievich AN, Kondakova AN, Valade E, Platonov ME, Vakhrameeva GM, Shaikhutdinova RZ, Mironova RI, Blaha D, Bakhteeva IV, Titareva GM, Kravchenko TB, Kombarova TI, Vidal D, Pavlov VM, Lindner B, Dyatlov IA, Knirel YA. 2010. Biological properties and structure of the lipopolysaccharide of a vaccine strain of Francisella tularensis generated by inactivation of a quorum sensing system gene qseC. Biochemistry (Mosc) 75:443-451.
18. Wang X, Wang Q, Yang M, Xiao J, Liu Q, Wu H, Zhang Y. 2011. QseBC controls flagellar motility, fimbrial hemagglutination and intracellular virulence in fish pathogen Edwardsiella tarda. Fish Shellfish Immunol 30:944-953. http://dx.doi.org/10.1016/j.fsi.2011.01.019.
19. Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. 2003. Bacteriahost communication: the language of hormones. Proc Natl Acad SciUSA 100:8951-8956. http://dx.doi.org/10.1073/pnas.1537100100.
20. Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V. 2006. The QseC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci U S A 103:10420-10425. http://dx.doi.org/10.1073/pnas.0604343103.
21. Hughes DT, Clarke MB, Yamamoto K, Rasko DA, Sperandio V. 2009. The QseC adrenergic signaling cascade in enterohemorrhagic E. coli (EHEC). PLoS Pathog 5:e1000553. http://dx.doi.org/10.1371/journal.ppat.1000553.
22. Kendall MM, Rasko DA, Sperandio V. 2007. Global effects of the cellto-cell signaling molecules Autoinducer-2, Autoinducer-3, and epinephrine in a luxS mutant of enterohemorrhagic Escherichia coli. Infect Immun 75:4875-4884. http://dx.doi.org/10.1128/IAI.00550-07.
23. Reading NC, Rasko DA, Torres AG, Sperandio V. 2009. The twocomponent system QseEF and the membrane protein QseG link adrenergic and stress sensing to bacterial pathogenesis. Proc Natl Acad Sci U S A 106:5889-5894. http://dx.doi.org/10.1073/pnas.0811409106.
24. Njoroge J, Sperandio V. 2012. Enterohemorrhagic Escherichia coli virulence regulation by two bacterial adrenergic kinases, QseC and QseE. Infect Immun 80:688-703. http://dx.doi.org/10.1128/IAI.05921-11.
25. Walters M, Sperandio V. 2006. Autoinducer 3 and epinephrine signaling in the kinetics of locus of enterocyte effacement gene expression in enterohemorrhagic Escherichia coli. Infect Immun 74:5445-5455. http://dx.doi.org/10.1128/IAI.00099-06.
26. Kendall MM, Rasko DA, Sperandio V. 2007. Global effects of the cellto-cell signaling molecules Autoinducer-2, Autoinducer-3, and epinephrine in a luxS mutant of enterohemorrhagic Escherichia coli. Infect Immun 75:4875-4884. http://dx.doi.org/10.1128/IAI.00550-07.
27. Kaper JB, O’BrienAD(ed). 1998. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains, 1st ed. ASM Press, Washington, DC.
28. Elliott SJ, Hutcheson SW, Dubois MS, Mellies JL, Wainwright LA, Batchelor M, Frankel G, Knutton S, Kaper JB. 1999. Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli. Mol Microbiol 33:1176-1189. http://dx.doi.org/10.1046/j.1365-2958.1999.01559.x.
29. Mellies JL, Elliott SJ, Sperandio V, Donnenberg MS, Kaper JB. 1999. The per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol 33: 296-306. http://dx.doi.org/10.1046/j.1365-2958.1999.01473.x.
30. Elliott SJ, Wainwright LA, McDaniel TK, Jarvis KG, Deng Y, Lai L, McNamara BP, Donnenberg MS, Kaper JB. 1998. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol 28:1-4. http://dx.doi.org/10.1046/j.1365-2958.1998.00783.x.
31. Jarvis KG, Girón JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci U S A 92:7996-8000. http://dx.doi.org/10.1073/pnas.92.17.7996.
32. Jerse AE, Yu J, Tall BD, Kaper JB. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87:7839-7843. http://dx.doi.org/10.1073/pnas.87.20.7839.
33. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520. http://dx.doi.org/10.1016/S0092-8674(00)80437-7.
34. McNamara BP, Donnenberg MS. 1998. A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. FEMS Microbiol Lett 166:71-78. http://dx.doi.org/10.1111/j.1574-6968.1998.tb13185.x.
35. Kenny B, Jepson M. 2000. Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol 2:579-590. http://dx.doi.org/10.1046/j.1462-5822.2000.00082.x.
36. Elliott SJ, Krejany EO, Mellies JL, Robins-Browne RM, Sasakawa C, Kaper JB. 2001. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun 69:4027-4033. http://dx.doi.org/10.1128/IAI.69.6.4027-4033.2001.
37. Tu X, Nisan I, Yona C, Hanski E, Rosenshine I. 2003. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol 47:595-606. http://dx.doi.org/10.1046/j.1365-2958.2003.03329.x.
38. Kanack KJ, Crawford JA, Tatsuno I, Karmali MA, Kaper JB. 2005. SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun 73: 4327-4337. http://dx.doi.org/10.1128/IAI.73.7.4327-4337.2005.
39. Dean-Nystrom EA, Bosworth BT, Cray WC, Jr, Moon HW. 1997. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun 65:1842-1848.
40. Dean-Nystrom EA, Bosworth BT, Moon HW, O’Brien AD. 1998. Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect Immun 66:4560-4563.
41. Dean-Nystrom EA, Gansheroff LJ, Mills M, Moon HW, O’Brien AD. 2002. Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection. Infect Immun 70: 2414-2418. http://dx.doi.org/10.1128/IAI.70.5.2414-2418.2002.
42. Dean-Nystrom EA, Pohlenz JF, Moon HW, O’Brien AD. 2000. Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets. Infect Immun 68: 2356-2358. http://dx.doi.org/10.1128/IAI.68.4.2356-2358.2000.
43. McKee ML, Melton-Celsa AR, Moxley RA, Francis DH, O’Brien AD. 1995. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun 63:3739-3744.
44. Wadolkowski EA, Burris JA, O’Brien AD. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157: H7. Infect Immun 58:2438-2445.
45. Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O’Brien AD. 1990. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 58:3959-3965.
46. Woods JB, Schmitt CK, Darnell SC, Meysick KC, O’Brien AD. 2002. Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli. J Infect Dis 185:550-554. http://dx.doi.org/10.1086/338633.
47. Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, Taylor FB. 2003. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92-96. http://dx.doi.org/10.1007/s00467-002-1035-7.
48. Siegler RL, Pysher TJ, Tesh VL, Taylor FB. 2002. Renal prostacyclin biosynthesis in a baboon model of Shiga toxin mediated hemolytic uremic syndrome. Nephron 92:363-368.
49. Ritchie JM, Thorpe CM, Rogers AB, Waldor MK. 2003. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 71: 7129-7139. http://dx.doi.org/10.1128/IAI.71.12.7129-7139.2003.
50. Ritchie JM, Waldor MK. 2005. The locus of enterocyte effacementencoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect Immun 73:1466-1474. http://dx.doi.org/10.1128/IAI.73.3.1466-1474.2005.
51. Mundy R, Pickard D, Wilson RK, Simmons CP, Dougan G, Frankel G. 2003. Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium. Mol Microbiol 48:795-809. http://dx.doi.org/10.1046/j.1365-2958.2003.03470.x.
52. Deng W, Puente JL, Gruenheid S, Li Y, Vallance BA, Vázquez A, Barba J, Ibarra JA, O’Donnell P, Metalnikov P, Ashman K, Lee S, Goode D, Pawson T, Finlay BB. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A 101: 3597-3602. http://dx.doi.org/10.1073/pnas.0400326101.
53. Finlay BB. 1999. Bacterial disease in diverse hosts. Cell 96:315-318. http://dx.doi.org/10.1016/S0092-8674(00)80544-9.
54. Gruenheid S, Sekirov I, Thomas NA, Deng W, O’Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB. 2004. Identification and characterization of NleA, a non-LEEencoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 51:1233-1249. http://dx.doi.org/10.1046/j.1365-2958.2003.03911.x.
55. Dougan G, Ghaem-Maghami M, Pickard D, Frankel G, Douce G, Clare S, Dunstan S, Simmons C. 2000. The immune responses to bacterial antigens encountered in vivo at mucosal surfaces. Philos Trans R Soc Lond B Biol Sci 355:-705-712. http://dx.doi.org/10.1098/rstb.2000.0610.
56. Hemrajani C, Marches O, Wiles S, Girard F, Dennis A, Dziva F, Best A, Phillips AD, Berger CN, Mousnier A, Crepin VF, Kruidenier L, Woodward MJ, Stevens MP, La Ragione RM, Macdonald TT, Frankel G. 2008. Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun 76:4804-4813. http://dx.doi.org/10.1128/IAI.00742-08.
57. Reading NC, Torres AG, Kendall MM, Hughes DT, Yamamoto K, Sperandio V. 2007. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J Bacteriol 189:2468-2476. http://dx.doi.org/10.1128/JB.01848-06.
58. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat Rev Microbiol 2:123-140. http://dx.doi.org/10.1038/nrmicro818.
59. Njoroge JW, Nguyen Y, Curtis MM, Moreira CG, Sperandio V. 2012. Virulence meets metabolism: CRA and KdpE gene regulation in enterohemorrhagic Escherichia coli. mBio 3:e00280-12. http://dx.doi.org/10.1128/mBio.00280-12.
60. García-Angulo VA, Martínez-Santos VI, Villaseñor T, Santana FJ, Huerta-Saquero A, Martínez LC, Jiménez R, Lara-Ochoa C, Téllez-Sosa J, Bustamante VH, Puente JL. 2012. A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli. J Bacteriol 194:5589-5603. http://dx.doi.org/10.1128/JB.00190-12.
61. Gruber CC, Sperandio V. 2014. Posttranscriptional control of microbeinduced rearrangement of host cell actin. mBio 5:e01025-13. http://dx.doi.org/10.1128/mBio.01025-13.
62. Gruber CC, Sperandio V. 2015. Global analysis of posttranscriptional regulation by GlmY and GlmZ in enterohemorrhagic Escherichia coli O157:H7. Infect Immun 83:1286-1295. http://dx.doi.org/10.1128/IAI.02918-14.
63. Curtis MM, Russell R, Moreira CG, Adebesin AM, Wang C, Williams NS, Taussig R, Stewart D, Zimmern P, Lu B, Prasad RN, Zhu C, Rasko DA, Huntley JF, Falck JR, Sperandio V. 2014. QseC inhibitors as an antivirulence approach for gram-negative pathogens. mBio 5:e02165. http://dx.doi.org/10.1128/mBio.02165-14.
64. Curtis MM, Hu Z, Klimko C, Narayanan S, Deberardinis R, Sperandio V. 2014. The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16:759-769. http://dx.doi.org/10.1016/j.chom.2014.11.005.
65. Luperchio SA, Schauer DB. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3:333-340. http://dx.doi.org/10.1016/S1286-4579(01)01387-9.
66. Alaniz RC, Thomas SA, Perez-Melgosa M, Mueller K, Farr AG, Palmiter RD, Wilson CB. 1999. Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc Natl Acad Sci USA 96:2274-2278. http://dx.doi.org/10.1073/pnas.96.5.2274.
67. Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG, Sperandio V. 2012. Fucose sensing regulates bacterial intestinal colonization. Nature 492:113-117. http://dx.doi.org/10.1038/nature11623.
68. Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, Núñez G. 2012. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336:1325-1329. http://dx.doi.org/10.1126/science.1222195.
69. Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB. 2011. Altering host resistance to infections through microbial transplantation. PLoS One 6:e26988. http://dx.doi.org/10.1371/journal.pone.0026988.
70. Spencer H, Karavolos MH, Bulmer DM, Aldridge P, Chhabra SR, Winzer K, Williams P, Khan CM. 2010. Genome-wide transposon mutagenesis identifies a role for host neuroendocrine stress hormones in regulating the expression of virulence genes in salmonella. J Bacteriol 192: 714-724. http://dx.doi.org/10.1128/JB.01329-09.
71. Hughes DT, Sperandio V. 2008. Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol 6:111-120. http://dx.doi.org/10.1038/nrmicro1836.
72. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161: 264-276. http://dx.doi.org/10.1016/j.cell.2015.02.047.
73. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. 2007. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2:204. http://dx.doi.org/10.1016/j.chom.2007.08.002.
74. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, Dougan G, von Mering C, Hardt WD. 2007. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5:2177-2189. http://dx.doi.org/10.1371/journal.pbio.0050244.
75. Yamamoto K, Hirao K, Oshima T, Aiba H, Utsumi R, Ishihama A. 2005. Functional characterization in vitro of all two-component signal transduction systems from Escherichia coli. J Biol Chem 280:1448-1456. http://dx.doi.org/10.1074/jbc.M410104200.
76. Kendall MM, Gruber CC, Rasko DA, Hughes DT, Sperandio V. 2011. Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24. J Bacteriol 193:6843-6851. http://dx.doi.org/10.1128/JB.06141-11.
77. Shakhnovich EA, Davis BM, Waldor MK. 2009. Hfq negatively regulates type III secretion in EHEC and several other pathogens. Mol Microbiol 74:347-363. http://dx.doi.org/10.1111/j.1365-2958.2009.06856.x.
78. Hansen AM, Kaper JB. 2009. Hfq affects the expression of the LEE pathogenicity island in enterohaemorrhagic Escherichia coli. Mol Microbiol 73: 446-465. http://dx.doi.org/10.1111/j.1365-2958.2009.06781.x.
79. Schauer DB, Falkow S. 1993. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect Immun 61:2486-2492.
80. Sampson TR, Mazmanian SK. 2015. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17:565-576. http://dx.doi.org/10.1016/j.chom.2015.04.011.
81. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
82. Ahmer BM, Thomas MG, Larsen RA, Postle K. 1995. Characterization of the exbBD operon of Escherichia coli and the role of ExbB and ExbD in TonB function and stability. J Bacteriol 177:4742-4747.
83. Thomas SA, Palmiter RD. 1998. Examining adrenergic roles in development, physiology, and behavior through targeted disruption of the mouse dopamine beta-hydroxylase gene. Adv Pharmacol 42:57-60.